Key result
Specific clinical outcomes for IV tPA in cancer patients with ischemic stroke remain unreported.
tPA may improve outcomes in cancer-associated stroke; hypothesis-generating and requires prospective validation before practice change.
To analyze outcomes of intravenous (IV) tissue plasminogen activator (tPA) in cancer patients.
No takes yet. Share an insight, caveat, or question.
Lobaina et al. (2026) studied this question. Intravenous tissue plasminogen activator (tPA) outcomes for ischemic stroke in cancer patients were analyzed, but specific clinical results were not reported in the provided abstract.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: